Cytomos Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cytomos Limited - overview
Established
2012
Location
Edinburgh, -, UK
Primary Industry
Biotechnology
About
Based in Edinburgh, UK, and founded in 2012 by its CEO Keith Muir, Cytomos Limited operates as a life science company that develops technology platforms for analyzing cells. In November 2024, Cytomos Limited raised GBP 5 million in venture funding led by Archangels Investors Limited, with participation from Old College Capital, Scottish Enterprise, and British Business Bank. Cytomos Limited offers Cytomos Dielectric Spectroscopy (CDS), a full-stack, single-cell resolution analysis technology, spanning integrated sensors through to machine learning-enhanced algorithms. It applies an electric field across single cells in suspension, measuring more than 16,000 frequencies per cell.
The company's platform enables quantitative and qualitative cytometry without the requirement for cell labelling reagents. The company will use the November 2024 funding to increase production of its cell-analysis technology and expand its team.
Current Investors
Archangels Investors Limited, Old College Capital, Scottish Enterprise
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics, Healthcare IT, Analytics & Performance Software
Website
www.cytomos.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.